Opportunity
DIBBS #SPE2DP-27-T-0282
DLA request for a package of premixed lidocaine and dextrose injection
Posted
November 12, 2026
Respond By
November 17, 2026
Identifier
SPE2DP-27-T-0282
NAICS
424210, 325412
DLA Troop Support is seeking one package of premixed lidocaine hydrochloride and dextrose injection for its Medical Supply Chain Pharmaceutical FSA. - Government buyer: Defense Logistics Agency (DLA), DLA Troop Support, Medical Supply Chain Pharmaceutical FSA; contact: Meghan Smink. - Product and quantity: 1 package of lidocaine hydrochloride and dextrose injection, 500 mL bags, 18 units per package (18 EA). - Identifiers: NSN 6505-01-194-7265; Baxter Healthcare Corp IV part number 2B0973P; NDC 00338-0409-03. - OEMs named: Baxter Healthcare Corp IV is the listed manufacturer. Hospira is also mentioned in connection with supply shortages. - Notable requirements: At least 16 months of the product's 18-month shelf life must remain when delivered. Delivery is required within 20 days after award. The notice describes limited supply availability and manufacturing delays affecting premixed lidocaine injections.
Description
LIDOCAINE HYDROCHLO (QTY: 1, NSN: 6505-01-194-7265, Purchase Request: 7013324492) Approved Sources: - CAGE: 04687, Part No: 2B0973P - CAGE: 04687, Part No: NDC00338-0409-03